Free Trial

Xylem Inc. $XYL Shares Bought by Flputnam Investment Management Co.

Xylem logo with Business Services background
Image from MarketBeat Media, LLC.

Key Points

  • Flputnam Investment Management Co. increased its stake in Xylem by 34.1% in the fourth quarter, adding 12,639 shares to bring its total holdings to 49,665 shares worth about $6.76 million.
  • Xylem reported better-than-expected quarterly results, posting $1.12 EPS on $2.13 billion in revenue, both slightly ahead of analyst estimates, with revenue up 2.7% year over year.
  • The company also announced a quarterly dividend of $0.43 per share and a new $1.5 billion share repurchase program, while analysts currently maintain a consensus rating of Moderate Buy with a $152.77 target price.
  • Five stocks to consider instead of Xylem.

Flputnam Investment Management Co. grew its holdings in shares of Xylem Inc. (NYSE:XYL - Free Report) by 34.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 49,665 shares of the industrial products company's stock after purchasing an additional 12,639 shares during the period. Flputnam Investment Management Co.'s holdings in Xylem were worth $6,763,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of XYL. Schroder Investment Management Group increased its stake in Xylem by 2,055.2% during the third quarter. Schroder Investment Management Group now owns 1,192,682 shares of the industrial products company's stock worth $171,687,000 after purchasing an additional 1,137,342 shares during the period. Balyasny Asset Management L.P. increased its stake in Xylem by 346.2% during the third quarter. Balyasny Asset Management L.P. now owns 712,950 shares of the industrial products company's stock worth $105,160,000 after purchasing an additional 553,152 shares during the period. Adage Capital Partners GP L.L.C. purchased a new stake in Xylem during the second quarter worth about $64,407,000. Jennison Associates LLC increased its stake in Xylem by 241.6% during the fourth quarter. Jennison Associates LLC now owns 633,648 shares of the industrial products company's stock worth $86,290,000 after purchasing an additional 448,148 shares during the period. Finally, Northwestern Mutual Wealth Management Co. increased its stake in Xylem by 2,309.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 431,824 shares of the industrial products company's stock worth $54,314,000 after purchasing an additional 413,904 shares during the period. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Xylem Stock Performance

Shares of Xylem stock opened at $110.11 on Thursday. The firm has a market capitalization of $26.17 billion, a P/E ratio of 27.39, a P/E/G ratio of 1.58 and a beta of 1.08. Xylem Inc. has a 52 week low of $105.29 and a 52 week high of $154.27. The company has a quick ratio of 1.10, a current ratio of 1.46 and a debt-to-equity ratio of 0.13. The firm's 50 day moving average is $118.30 and its two-hundred day moving average is $130.20.

Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings results on Tuesday, April 28th. The industrial products company reported $1.12 EPS for the quarter, beating the consensus estimate of $1.09 by $0.03. The company had revenue of $2.13 billion for the quarter, compared to analyst estimates of $2.11 billion. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The firm's revenue was up 2.7% on a year-over-year basis. During the same period in the prior year, the firm posted $1.03 earnings per share. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Research analysts forecast that Xylem Inc. will post 5.51 EPS for the current fiscal year.

Xylem Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Thursday, May 28th will be paid a $0.43 dividend. This represents a $1.72 annualized dividend and a yield of 1.6%. The ex-dividend date is Thursday, May 28th. Xylem's dividend payout ratio is currently 42.79%.

Xylem declared that its Board of Directors has initiated a share repurchase program on Wednesday, February 25th that allows the company to buyback $1.50 billion in outstanding shares. This buyback authorization allows the industrial products company to purchase up to 4.8% of its stock through open market purchases. Stock buyback programs are usually an indication that the company's management believes its stock is undervalued.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on XYL. The Goldman Sachs Group set a $158.00 target price on shares of Xylem in a research note on Wednesday, February 11th. Weiss Ratings lowered shares of Xylem from a "hold (c+)" rating to a "hold (c)" rating in a research note on Friday, May 8th. Royal Bank Of Canada cut their target price on shares of Xylem from $176.00 to $162.00 and set an "outperform" rating on the stock in a research note on Wednesday, February 11th. Stifel Nicolaus cut their target price on shares of Xylem from $163.00 to $159.00 and set a "buy" rating on the stock in a research note on Wednesday, April 29th. Finally, Citigroup cut their target price on shares of Xylem from $174.00 to $168.00 and set a "buy" rating on the stock in a research note on Wednesday, April 29th. Seven analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $152.77.

Check Out Our Latest Stock Analysis on Xylem

Insider Activity at Xylem

In other Xylem news, CAO Geri-Michelle Mcshane sold 4,269 shares of the stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total value of $501,436.74. Following the transaction, the chief accounting officer directly owned 3,605 shares in the company, valued at $423,443.30. This represents a 54.22% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Jerome A. Peribere purchased 1,210 shares of the company's stock in a transaction on Monday, May 4th. The stock was bought at an average price of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the purchase, the director directly owned 27,209 shares of the company's stock, valued at $3,172,841.49. The trade was a 4.65% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 0.32% of the company's stock.

About Xylem

(Free Report)

Xylem Inc NYSE: XYL is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

Featured Articles

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL - Free Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines